TREMFYA

Formula & Concentration

TREMFYA- guselkumab injection

Manufacturer

JOM Pharmaceutical Services Inc.

Indications

TREMFYA is an interleukin-23 antagonist indicated for the treatment of adult patients with:

moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy ( 1.1)
active psoriatic arthritis ( 1.2)
moderately to severely active ulcerative colitis ( 1.3)
moderately to severely active Crohn’s disease

Product Options

Package Size

NDC #

Presentation

100 mg

57894-0640-01

Prefilled syringe

100 mg

57894-0640-06

Prefilled syringe

100 mg

57894-0640-11

Solution

200 mg

57894-0651-02

Solution

200 mg

57894-0650-02

Vial

200 mg

57894-0651-04

Prefilled syringe

200 mg

57894-0651-22

Prefilled syringe

Shelf Life and Storage

TREMFYA is sterile and preservative-free. Discard any unused portion.

Store in a refrigerator between 2°C to 8°C (36°F to 46°F).
Store in original carton until time of use.
Protect from light until use.
Do not freeze.
Do not shake.
Not made with natural rubber latex.